We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

204 hedge funds and large institutions have $3.47B invested in IDEAYA Biosciences in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 78 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 12

132% more call options, than puts

Call options by funds: $1.4M | Put options by funds: $601K

50% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 52

45% more capital invested

Capital invested by funds: $2.4B → $3.47B (+$1.07B)

30% more funds holding

Funds holding: 157204 (+47)

1.53% more ownership

Funds ownership: 104.51%106.05% (+1.5%)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
204
Holders Change
+47
Holders Change %
+29.94%
% of All Funds
2.94%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
59
Increased
78
Reduced
52
Closed
12
Calls
$1.4M
Puts
$601K
Net Calls
+$794K
Net Calls Change
+$505K
Name Holding Trade Value Shares
Change
Change in
Stake
AIP
151
Ameritas Investment Partners
Nebraska
$288K +$14.3K +332 +5%
ETC
152
Exchange Traded Concepts
Oklahoma
$279K +$66.8K +1,554 +32%
SRL
153
Scientech Research LLC
New Jersey
$263K +$258K +5,994 New
XT
154
XTX Topco
Cayman Islands
$257K +$252K +5,850 New
DTL
155
Dynamic Technology Lab
Singapore
$248K +$243K +5,645 New
Mitsubishi UFJ Asset Management
156
Mitsubishi UFJ Asset Management
Japan
$243K -$10.9K -254 -4%
FCM
157
Farallon Capital Management
California
$219K +$215K +5,000 New
OC
158
Oppenheimer & Co
New York
$217K +$212K +4,942 New
OAM
159
Oxford Asset Management
United Kingdom
$214K +$210K +4,888 New
OSAM
160
O'Shaughnessy Asset Management
Connecticut
$214K +$210K +4,877 New
State Board of Administration of Florida Retirement System
161
State Board of Administration of Florida Retirement System
Florida
$171K -$137K -3,180 -20%
IA
162
IFP Advisors
Florida
$164K +$160K +3,732 New
MLICM
163
Metropolitan Life Insurance Company (MetLife)
New York
$152K +$1.25K +29 +0.8%
BG
164
Bellevue Group
Switzerland
$145K +$142K +3,300 New
PD
165
Point72 (DIFC)
United Arab Emirates
$131K +$129K +2,994 New
VEA
166
Virtus ETF Advisers
New York
$111K -$7.31K -170 -6%
Nisa Investment Advisors
167
Nisa Investment Advisors
Missouri
$106K +$2.19K +51 +2%
SG Americas Securities
168
SG Americas Securities
New York
$101K +$99K +2,303 New
AB
169
Amalgamated Bank
New York
$97K -$218K -5,073 -70%
HF
170
Halpern Financial
Virginia
$94.8K
PA
171
Parallel Advisors
California
$75.4K +$67.8K +1,577 +1,111%
JEST
172
JTC Employer Solutions Trustee
Jersey
$67K +$66.5K +1,547 New
Comerica Bank
173
Comerica Bank
Texas
$66.1K +$56.9K +1,324 +723%
Osaic Holdings
174
Osaic Holdings
Arizona
$65.9K +$60.9K +1,417 +1,687%
Simplex Trading
175
Simplex Trading
Illinois
$65K +$64.4K +1,497 New

IDYA Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2024, worth a combined $3.47B — up 45% from $2.4B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new IDYA positions and 12 closed out — a net gain of 47 holders — while 78 added to existing stakes and 52 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $398M. The largest seller was Morgan Stanley, cutting an estimated $73.2M.

  • 204 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2024, up from 157 in Q4 2023.
  • Funds reported $3.47B of IDEAYA Biosciences stock for Q1 2024, up 45% quarter-over-quarter.
  • 59 funds opened new IDEAYA Biosciences positions in Q1 2024 and 12 closed out, a net change of +47 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2024 was Fidelity Investments, an estimated $398M added.
  • The largest IDEAYA Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $73.2M sold.

Based on aggregated 13F filings for Q1 2024.